0A8S Stock Chart & Stats
$1.53
-$0.29(-7.48%)
At close: 4:00 PM EST
$1.53
-$0.29(-7.48%)
Day’s Range― - ―
52-Week Range$1.40 - $5.27
Previous CloseN/A
Volume150.00
Average Volume (3M)218.00
Market Cap
$12.53M
Enterprise Value$8.63
Total Cash (Recent Filing)$3.59M
Total Debt (Recent Filing)$3.05M
Price to Earnings (P/E)―
Beta2.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,664,534
10 Day Avg. Volume110
30 Day Avg. Volume218
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$8.00Price Target Upside422.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross-Margin ImprovementThe sharp improvement in quarterly revenue and gross margin indicates stronger product traction, pricing, and sales mix. If these gains extend beyond the current small base, they could improve operating leverage, support reinvestment, and strengthen the economics of SINTX’s commercialization strategy.
FDA-Cleared Medical Platform And Distribution ExpansionFDA clearance removes a major commercialization barrier for the SiNAPTIC system, while a broader distributor network expands access to orthopedic customers. Together, these milestones create a more durable route to market and can support adoption of SINTX’s silicon nitride technology.
Industrial Orders And Revenue DiversificationThe industrial ceramics business provides a second commercial channel while medical technologies continue developing. Purchase orders and initiated shipments offer a potential revenue base that can help fund higher-growth programs, reduce dependence on one market, and validate broader demand for the company’s materials platform.
Bears Say
Persistent Cash Burn And Going-Concern RiskSustained negative operating and free cash flow means the business is not currently funding operations internally. Combined with the explicit going-concern warning, this can constrain investment, increase reliance on external capital, and make execution more vulnerable if financing conditions or fundraising access deteriorate.
Unprofitable Operating Model And Rising ExpensesPersistent gross losses, large operating losses, and rising expenses show that commercialization has not yet produced a scalable profit model. Unless revenue growth converts into consistent positive margins, higher spending can continue widening funding needs and limit the company’s ability to build durable earnings power.
Uncertain Conversion Of Purchase Orders Into RevenueThe announced orders provide potential visibility but are not equivalent to contracted, recognized revenue. Multiple production, quality, delivery, and customer-acceptance conditions create execution risk, so revenue timing may remain uneven and forecasts may not translate into sustained growth without successful fulfillment.
Sintx Technologies News
0A8S FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest share price was $1.40 and its highest was $5.27 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is $12.53M.
When is Sintx Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sintx Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 6,664,534 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in GB:0A8S
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
0A8S Earnings Call
Q2 2026
0:00 / 0:00
0A8S Stock 12 Month Forecast
Average Price Target
$8.00
▲(422.88% Upside)
Technical Analysis
Integra Lifesciences
―
Medtronic
―
Orthofix Medical
―
Stryker
―
Zimmer Biomet Holdings
―